Do Justin P. Canakis
Do Justin P. Canakis has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Adrienne White
Arizona State University, Phoenix, Arizona
1 shared publication- Ba Matthew P. Momjian
Philadelphia College of Osteopathic Medicine, Philadelphia, Pennsylvania. ORCID: https://orcid.org/
1 shared publication Bs Hayden Pond
HonorHealth, Scottsdale, Arizona
1 shared publicationDhsc Alison C. Essary
HonorHealth, Scottsdale, Arizona
1 shared publicationDo Faraz Yousefian
University of the Incarnate Word School of Osteopathic Medicine, San Antonio, Texas
1 shared publication- Fariha Hasan
Department of Internal Medicine, Cooper University Hospital, Camden, NJ, USA
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in Gastroenterology Research and Practice
- Vol. 2026 (1)
The Mediterranean Diet and Inflammatory Bowel Disease: A Comprehensive Systematic Review and Meta‐Analysis
Introduction: Diet significantly influences the progression of inflammatory bowel disease (IBD). The Mediterranean diet (MD), characterized by high consumption of fruits, vegetables, healthy fats, lean proteins, and limited intake of processed foods, is recommended as adjunctive therapy. This meta‐analysis is aimed at evaluating existing data on dietary management in ulcerative colitis (UC) and assessing the effectiveness of MD in achieving symptomatic remission or improvement in IBD patients compared with other dietary interventions. Methods: Following Cochrane and PRISMA guidelines, we compared MD with alternative dietary interventions in IBD patients. Randomized controlled trials (RCTs) were identified through comprehensive database searches up to November 2024. Data were analyzed using RevMan Web, employing a random‐effects model. Results: Four RCTs involving a total of 339 IBD patients were included in this analysis. Among these, 167 patients (UC and CD) received the MD, whereas 172 followed non‐Mediterranean diets (NMD). The MD was associated with a statistically significant improvement in clinical remission compared with NMD (RR 1.18, p = 0.02). In subgroup analyses, clinical remission was not statistically different in UC (RR 1.15, 95% CI: 0.94–1.41, p = 0.78) or CD (RR 1.22, 95% CI: 1.00–1.47, p = 0.05). When compared specifically with a regular diet, MD significantly reduced both CRP levels (MD −2.66, p < 0.00001) and fecal calprotectin (MD −229.46, p = 0.008). Specifically, within the UC population, MD significantly decreased CRP and fecal calprotectin levels. Discussion: Our findings indicate that the MD significantly benefits IBD management, especially UC, as demonstrated by notable reductions in inflammatory markers. Benefits in CD remain unclear despite prior evidence. Future research should clarify benefits across patient subgroups and address adherence challenges.
- 1 January 2026
- Published by Wiley in Gastroenterology Research and Practice
- Vol. 2026 (1)
Open AccessThe Mediterranean Diet and Inflammatory Bowel Disease: A Comprehensive Systematic Review and Meta‐Analysis
Introduction: Diet significantly influences the progression of inflammatory bowel disease (IBD). The Mediterranean diet (MD), characterized by high consumption of fruits, vegetables, healthy fats, lean proteins, and limited intake of processed foods, is recommended as adjunctive therapy. This meta‐analysis is aimed at evaluating existing data on dietary management in ulcerative colitis (UC) and assessing the effectiveness of MD in achieving symptomatic remission or improvement in IBD patients compared with other dietary interventions. Methods: Following Cochrane and PRISMA guidelines, we compared MD with alternative dietary interventions in IBD patients. Randomized controlled trials (RCTs) were identified through comprehensive database searches up to November 2024. Data were analyzed using RevMan Web, employing a random‐effects model. Results: Four RCTs involving a total of 339 IBD patients were included in this analysis. Among these, 167 patients (UC and CD) received the MD, whereas 172 followed non‐Mediterranean diets (NMD). The MD was associated with a statistically significant improvement in clinical remission compared with NMD (RR 1.18, p = 0.02). In subgroup analyses, clinical remission was not statistically different in UC (RR 1.15, 95% CI: 0.94–1.41, p = 0.78) or CD (RR 1.22, 95% CI: 1.00–1.47, p = 0.05). When compared specifically with a regular diet, MD significantly reduced both CRP levels (MD −2.66, p < 0.00001) and fecal calprotectin (MD −229.46, p = 0.008). Specifically, within the UC population, MD significantly decreased CRP and fecal calprotectin levels. Discussion: Our findings indicate that the MD significantly benefits IBD management, especially UC, as demonstrated by notable reductions in inflammatory markers. Benefits in CD remain unclear despite prior evidence. Future research should clarify benefits across patient subgroups and address adherence challenges.
- 1 January 2023
- Published by Weston Medical Publishing in Journal of Opioid Management
- Vol. 19 (1) , 11-18
Building a community of experts in medication-assisted treatment (MAT) using the Project ECHO© model
Background: Project Extension for Community Healthcare Outcomes (ECHO) utilizes telemedicine to connect a multidisciplinary team of experts with a network of primary care physicians to enable rapid dissemination of evidence-based guidelines and practices at scale. In this study, the Project ECHO model disseminated the Arizona Pain and Addiction Curriculum to providers in rural Arizona with the goal to educate providers on medication-assisted treatment (MAT). Methods: Participants engaged in biweekly, virtual teleECHO sessions, and post-session surveys were used to collect data on provider satisfaction, self-efficacy, knowledge, barriers to change, and changes in practice behavior. Results: Between February 2020 and November 2020, the MAT-ECHO program hosted 20 teleECHO sessions (N = 20) with 255 unique participating providers and delivered 877 learning hours. Analysis of a 6-month post-ECHO survey (N = 13) demonstrated that teleECHO sessions had broad geographic outreach. Participants had an average of 12 years of experience, 38 percent held NP/PA professional degrees, and 54 percent practiced in opioid treatment program settings. Assessment of job satisfaction and well-being revealed overall improved satisfaction among the small cohort of nonwaivered respondents (N = 8), except for meeting patient’s needs. MAT-waivered respondents reported no post-session changes. Conclusions: Data from this study demonstrated that teleECHO sessions were well attended, consisted of a diverse cohort with various degrees, and had broad geographic outreach; hence, the utilization of the teleECHO model has the potential to reach rural providers and subsequently increase the availability and efficacy of MAT in rural America.
- 1 January 2023
- Published by Weston Medical Publishing in Journal of Opioid Management
- Vol. 19 (1) , 11-18
Building a community of experts in medication-assisted treatment (MAT) using the Project ECHO© model
Background: Project Extension for Community Healthcare Outcomes (ECHO) utilizes telemedicine to connect a multidisciplinary team of experts with a network of primary care physicians to enable rapid dissemination of evidence-based guidelines and practices at scale. In this study, the Project ECHO model disseminated the Arizona Pain and Addiction Curriculum to providers in rural Arizona with the goal to educate providers on medication-assisted treatment (MAT). Methods: Participants engaged in biweekly, virtual teleECHO sessions, and post-session surveys were used to collect data on provider satisfaction, self-efficacy, knowledge, barriers to change, and changes in practice behavior. Results: Between February 2020 and November 2020, the MAT-ECHO program hosted 20 teleECHO sessions (N = 20) with 255 unique participating providers and delivered 877 learning hours. Analysis of a 6-month post-ECHO survey (N = 13) demonstrated that teleECHO sessions had broad geographic outreach. Participants had an average of 12 years of experience, 38 percent held NP/PA professional degrees, and 54 percent practiced in opioid treatment program settings. Assessment of job satisfaction and well-being revealed overall improved satisfaction among the small cohort of nonwaivered respondents (N = 8), except for meeting patient’s needs. MAT-waivered respondents reported no post-session changes. Conclusions: Data from this study demonstrated that teleECHO sessions were well attended, consisted of a diverse cohort with various degrees, and had broad geographic outreach; hence, the utilization of the teleECHO model has the potential to reach rural providers and subsequently increase the availability and efficacy of MAT in rural America.